Literature DB >> 19248123

Scleroderma prevalence: demographic variations in a population-based sample.

S Bernatsky1, L Joseph, C A Pineau, P Belisle, M Hudson, A E Clarke.   

Abstract

OBJECTIVE: To estimate the prevalence of systemic sclerosis (SSc) using population-based administrative data, and to assess the sensitivity of case ascertainment approaches.
METHODS: We ascertained SSc cases from Quebec physician billing and hospitalization databases (covering approximately 7.5 million individuals). Three case definition algorithms were compared, and statistical methods accounting for imperfect case ascertainment were used to estimate SSc prevalence and case ascertainment sensitivity. A hierarchical Bayesian latent class regression model that accounted for possible between-test dependence conditional on disease status estimated the effect of patient characteristics on SSc prevalence and the sensitivity of the 3 ascertainment algorithms.
RESULTS: Accounting for error inherent in both the billing and the hospitalization data, we estimated SSc prevalence in 2003 at 74.4 cases per 100,000 women (95% credible interval [95% CrI] 69.3-79.7) and 13.3 cases per 100,000 men (95% CrI 11.1-16.1). Prevalence was higher for older individuals, particularly in urban women (161.2 cases per 100,000, 95% CrI 148.6-175.0). Prevalence was lowest in young men (in rural areas, as low as 2.8 cases per 100,000, 95% CrI 1.4-4.8). In general, no single algorithm was very sensitive, with point estimates for sensitivity ranging from 20-73%.
CONCLUSION: We found marked differences in SSc prevalence according to age, sex, and region. In general, no single case ascertainment approach was very sensitive for SSc. Therefore, using data from multiple sources, with adjustment for the imperfect nature of each, is an important strategy in population-based studies of SSc and similar conditions.

Entities:  

Mesh:

Year:  2009        PMID: 19248123     DOI: 10.1002/art.24339

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?

Authors:  Ramya Janardana; Aswin M Nair; Ajit K Surin; John Anthony Jude Prakash; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2019-07-15       Impact factor: 2.980

Review 3.  Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Dermatology       Date:  2016-03-25       Impact factor: 5.366

4.  New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Authors:  Brett D Thombs; Lisa R Jewett; Shervin Assassi; Murray Baron; Susan J Bartlett; Angela Costa Maia; Ghassan El-Baalbaki; Daniel E Furst; Karen Gottesman; Jennifer A Haythornthwaite; Marie Hudson; Ann Impens; Annett Korner; Catarina Leite; Maureen D Mayes; Vanessa L Malcarne; Sarosh J Motivala; Luc Mouthon; Warren R Nielson; Diane Plante; Serge Poiraudeau; Janet L Poole; Janet Pope; Maureen Sauve; Russell J Steele; Maria E Suarez-Almazor; Suzanne Taillefer; Cornelia H van den Ende; Erin Arthurs; Marielle Bassel; Vanessa Delisle; Katherine Milette; Allison Leavens; Ilya Razykov; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

Review 5.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

Review 6.  Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets.

Authors:  Cristiano Sacchetti; Nunzio Bottini
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

7.  Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.

Authors:  Pravitt Gourh; Sandeep K Agarwal; Dipal Divecha; Shervin Assassi; Gene Paz; Rajpreet K Arora-Singh; John D Reveille; Sanjay Shete; Maureen D Mayes; Frank C Arnett; Filemon K Tan
Journal:  Arthritis Rheum       Date:  2009-12

8.  Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.

Authors:  Matteo Piga; Laura Casula; Silvia Sanna; Daniela Perra; Alberto Floris; Antonello Antonelli; Alberto Cauli; Alessandro Mathieu
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

9.  Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.

Authors:  Paul Bălănescu; Anca Lădaru; Eugenia Bălănescu; Theodor Voiosu; Cristian Băicuş; Gheorghe Andrei Dan
Journal:  J Clin Lab Anal       Date:  2015-09-01       Impact factor: 2.352

Review 10.  Is pregnancy a risk factor for rheumatic autoimmune diseases?

Authors:  Wendy Marder; Emily C Somers
Journal:  Curr Opin Rheumatol       Date:  2014-05       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.